期刊文献+

非小细胞肺癌的中西医分型分期相关性研究 被引量:27

TCM syndrome distribution of non-small cell lung cancer in different pathological type and clinical stage
下载PDF
导出
摘要 目的了解非小细胞肺癌的西医分型分期与中医证候分布的关系,指导临床诊断治疗。方法选取符合入选标准的经病理学确诊为非小细胞肺癌共计383例,采用调查表形式,收集入选患者的临床资料,包括组织临床分期、病理类型和治疗前的中医证候情况等。结果Ⅰ期肺癌与Ⅲ期肺癌比较,中医证型分布有统计学意义(P<0.05),Ⅰ期肺癌与Ⅳ期肺癌比较,中医证型分布有统计学意义(P<0.01),Ⅱ期肺癌与Ⅲ、Ⅳ期肺癌比较,中医证型分布有统计学意义(均P<0.01),Ⅰ期肺癌与Ⅱ期肺癌比较,Ⅲ期肺癌与Ⅳ期肺癌比较,中医证型分布无统计学意义(P>0.05)。不同病理类型肺癌的中医证型分别无明显差异(P>0.05)。结论非小细胞肺癌TNM分期与患者中医证型分布有相关性,但是肺癌病理类型与中医证型分布无明显相关性。 Objective To investigate TCM syndrome distribution of non-small cell lung cancer and find its relationship with clinic stages and histopathological types to treat the diseases. Methods The 383 cases diagnosed with non-small cell lung cancer were investigated by questionnaire. Clinical data of patients was collected,including clinical stages,histological type and syndromes of the diseases. Results Comparing in stage I,TCM syndrome distribution of the patients was statistically different in stage III lung cancer( P〈0. 05) and statistically different in stage IV lung cancer.Comparing in stage II,TCM syndrome distribution of the patients was statistically different in stage III and IV lung cancer( P〈0. 01). TCM syndrome distribution of the patients was no big different in between stage III and IV( P〈0. 01).,and so was in between stage I and II( P〉0. 05). TCM syndrome distribution of the patients was no big different statistically in different pathological types( P〉0. 05). Conclusion There is obvious correlation between TCM syndrome distribution of the patients and their clinical stages,but TCM syndrome distribution of the patients was no big different statistically in different pathological types.
出处 《吉林中医药》 2015年第4期358-360,共3页 Jilin Journal of Chinese Medicine
基金 广东省中医药管理局资助项目(20131134)
关键词 非小细胞肺癌 病理型 临床分期 中医证候 non-small cell lung cancer pathological type clinical stage TCM syndrome distribution
  • 相关文献

参考文献6

二级参考文献43

  • 1顾梦飚.480例原发性肺癌中医证型与国际TNM分期相关分析[J].上海中医药杂志,1994,28(1):1-3. 被引量:69
  • 2陈贡斌.艾迪注射液联合全身化疗治疗晚期非小细胞肺癌疗效观察[J].中国医药,2007,2(6):333-334. 被引量:7
  • 3沈自尹 王文健.中医虚证辨证参考标准[J].中西医结合杂志,1986,6(10):598-598.
  • 4刘嘉湘.辨证治疗原发性肺癌310例疗效分析[J].上海中医药杂志,1985,(10):3-3.
  • 5冷方南.中医证候辨证规范[M].北京:人民卫生出版社,1991:40.
  • 6American Cancer Society. Cancer Facts and Figueres [R]. Atlanta: American Cancer Society, 2006 : 13 - 14.
  • 7ELIAS A D.Small cell lung cancer:state of the art therapy in 1996[J].Chest,1997,112(4 Supp):251S-258S.
  • 8SCHIiJER J H.Carcinoma of the lung.In:Skeel RT,Lachant NA eds.Handbook of cancer chemotherapy [ M ].4^th ed.Boston MA:Little Brown and Company,1995:221-235.
  • 9ROTH B J,JOHNSON D H,EINHORN L H,et al.Randomized study of cyclophosphamide,doxorubicin,and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer:a phase Ⅲ trial of Southeastern Cancer Study Group [ J ].Clin Oncol,1992,10(2):282-291.
  • 10FUKUOKA M,FURUSE K,SAIJO N,et al.Randomized trial of cyclophosphamide,doxorubicin,and vincristine versus cisplatin and etoposide versus alternation of these two regimens in small-cell lung cancer [ J ].Natl Cancer Inst,1991,83(12):855-861.

共引文献362

同被引文献353

引证文献27

二级引证文献216

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部